Adragasib (Usage)
Adragasib is a small molecule inhibitor that targets a specific protein called BRAF. BRAF is a gene that can become mutated in certain types of cancer, leading to uncontrolled cell growth.
Potential Uses of Adragasib
Adragasib is primarily being studied for its potential use in treating melanoma, a type of skin cancer. It may also be effective in treating other cancers that have BRAF mutations, such as non-small cell lung cancer and colorectal cancer.
Adragasib is currently under development and has not yet been approved for widespread use. However, clinical trials are ongoing to evaluate its safety, efficacy, and potential side effects in patients with various types of cancer.
It’s important to note that adragasib is not a cure for cancer. It is a potential treatment option that may be effective for some patients, but the overall outcome will depend on individual factors.